组织芯片，组织微阵列

MMC963	多器官肿瘤及正常组织组合芯片，附病理分级、TNM和临床分期，13例/96点
点数	96	例数	13
行数	8	列数	12
点直径(mm)	1.0	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:	Cer -Cerebrum Ski -Skin Thy -Thyroid Liv -Liver Sto -Stomach Pan -Pancreas Tes -Testis Ova -Ovary Bre -Breast Col -Colon Lun -Lung Pro -Prostate
	AT () Malignant () Malignant (I) Malignant (IB) Malignant (II) Malignant (IIA) Malignant (IIB) Malignant (III) NAT () Normal ()

TISSUE ARRAYS MMC963

PRO

LUN

COL

PRO

LUN

COL

BRE

OVA

TES

BRE

OVA

TES

PAN

STO

LIV

PAN

STO

LIV

THY

SKI

CER

THY

SKI

CER

PRO

LUN

COL

PRO

LUN

COL

BRE

OVA

TES

BRE

OVA

TES

PAN

STO

LIV

PAN

STO

LIV

THY

SKI

CER

THY

SKI

CER

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	70	M	Prostate	Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5)	3	T2N0M0	II	Malignant	N
A2	2	70	M	Prostate	Adjacent normal prostate tissue (chronic inflammation)	*	*	*	NAT	N
A3	3	55	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	N
A4	4	55	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	N
A5	5	54	M	Colon	Adenocarcinoma	2	T2N0M0	I	Malignant	N
A6	6	54	M	Colon	Adjacent normal colon tissue	*	*	*	NAT	N
A7	7	70	M	Prostate	Adenocarcinoma (sparse)	*	T2N0M0	II	Malignant	N
A8	8	70	M	Prostate	Adjacent normal prostate tissue (sparse)	*	*	*	NAT	N
A9	9	55	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	N
A10	10	55	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	N
A11	11	54	M	Colon	Adenocarcinoma	2	T2N0M0	I	Malignant	N
A12	12	54	M	Colon	Adjacent normal colon tissue	*	*	*	NAT	N
B1	13	40	F	Breast	Invasive ductal carcinoma	2	T2N1M0	IIB	Malignant	N
B2	14	40	F	Breast	Adjacent normal breast tissue (sparse)	*	*	*	NAT	N
B3	15	68	F	Ovary	Serous adenocarcinoma	*	T2N0M0	II	Malignant	N
B4	16	68	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	N
B5	17	43	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
B6	18	43	M	Testis	Cancer adjacent testis tissue	*	*	*	AT	N
B7	19	40	F	Breast	Invasive ductal carcinoma	2	T2N1M0	IIB	Malignant	N
B8	20	40	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	N
B9	21	68	F	Ovary	Serous adenocarcinoma	2	T2N0M0	II	Malignant	N
B10	22	68	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	N
B11	23	43	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
B12	24	43	M	Testis	Cancer adjacent testis tissue	*	*	*	AT	N
C1	25	73	F	Pancreas	Duct adenocarcinoma	3	T2N0M0	IB	Malignant	N
C2	26	73	F	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	N
C3	27	78	F	Stomach	Adenocarcinoma	2	T3N0M0	IIA	Malignant	N
C4	28	78	F	Stomach	Adjacent normal stomach tissue	*	*	*	NAT	N
C5	29	43	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	N
C6	30	43	M	Liver	Liver tissue	*	*	*	Normal	N
C7	31	73	F	Pancreas	Duct adenocarcinoma	*	T2N0M0	IB	Malignant	N
C8	32	73	F	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	N
C9	33	78	F	Stomach	Adenocarcinoma	2	T3N0M0	IIA	Malignant	N
C10	34	78	F	Stomach	Adjacent normal stomach tissue	*	*	*	NAT	N
C11	35	43	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	N
C12	36	43	M	Liver	Liver tissue	*	*	*	Normal	N
D1	37	56	M	Thyroid	Papillary carcinoma	*	T2N0M0	II	Malignant	N
D2	38	56	M	Thyroid	Cancer adjacent thyroid tissue	*	*	*	AT	N
D3	39	52	M	Skin	Malignant melanoma of right heel	*	T4N1M0	III	Malignant	N
D4	40	52	M	Skin	Cancer adjacent skin tissue	*	*	*	AT	N
D5	41	51	M	Cerebrum	Glioma sarcomatosum of left temporal lobe	4	*	*	Malignant	N
D6	42	51	M	Cerebrum	Cancer adjacent cerebrum tissue	*	*	*	AT	N
D7	43	56	M	Thyroid	Papillary carcinoma	*	T2N0M0	II	Malignant	N
D8	44	56	M	Thyroid	Cancer adjacent thyroid tissue with canceration of follicular epithelium	*	*	*	AT	N
D9	45	52	M	Skin	Malignant melanoma of right heel	*	T4N1M0	III	Malignant	N
D10	46	52	M	Skin	Cancer adjacent skin tissue	*	*	*	AT	N
D11	47	51	M	Cerebrum	Glioma sarcomatosum of left temporal lobe	4	*	*	Malignant	N
D12	48	51	M	Cerebrum	Cancer adjacent cerebrum tissue	*	*	*	AT	N
E1	49	70	M	Prostate	Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5)	3	T2N0M0	II	Malignant	N
E2	50	70	M	Prostate	Adjacent normal prostate tissue (chronic inflammation)	*	*	*	NAT	N
E3	51	55	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	N
E4	52	55	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	N
E5	53	54	M	Colon	Adenocarcinoma	2	T2N0M0	I	Malignant	N
E6	54	54	M	Colon	Adjacent normal colon tissue	*	*	*	NAT	N
E7	55	70	M	Prostate	Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5)	3	T2N0M0	II	Malignant	N
E8	56	70	M	Prostate	Adjacent normal prostate tissue	*	*	*	NAT	N
E9	57	55	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	N
E10	58	55	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	N
E11	59	54	M	Colon	Adenocarcinoma	3	T2N0M0	I	Malignant	N
E12	60	54	M	Colon	Adjacent normal colon tissue (sparse)	*	*	*	NAT	N
F1	61	40	F	Breast	Invasive ductal carcinoma	2	T2N1M0	IIB	Malignant	N
F2	62	40	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	N
F3	63	68	F	Ovary	Serous adenocarcinoma (sparse)	*	T2N0M0	II	Malignant	N
F4	64	68	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	N
F5	65	43	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
F6	66	43	M	Testis	Cancer adjacent testis tissue	*	*	*	AT	N
F7	67	40	F	Breast	Invasive ductal carcinoma	2	T2N1M0	IIB	Malignant	N
F8	68	40	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	N
F9	69	68	F	Ovary	Serous adenocarcinoma (sparse)	*	T2N0M0	II	Malignant	N
F10	70	68	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	N
F11	71	43	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
F12	72	43	M	Testis	Cancer adjacent testis tissue	*	*	*	AT	N
G1	73	73	F	Pancreas	Duct adenocarcinoma	3	T2N0M0	IB	Malignant	N
G2	74	73	F	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	N
G3	75	78	F	Stomach	Adenocarcinoma	2	T3N0M0	IIA	Malignant	N
G4	76	78	F	Stomach	Adjacent normal stomach tissue	*	*	*	NAT	N
G5	77	43	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	N
G6	78	43	M	Liver	Liver tissue	*	*	*	Normal	N
G7	79	73	F	Pancreas	Duct adenocarcinoma	*	T2N0M0	IB	Malignant	N
G8	80	73	F	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	N
G9	81	78	F	Stomach	Adenocarcinoma	2--3	T3N0M0	IIA	Malignant	N
G10	82	78	F	Stomach	Adjacent normal stomach tissue	*	*	*	NAT	N
G11	83	43	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	N
G12	84	43	M	Liver	Liver tissue	*	*	*	Normal	N
H1	85	56	M	Thyroid	Papillary carcinoma	*	T2N0M0	II	Malignant	N
H2	86	56	M	Thyroid	Cancer adjacent thyroid tissue	*	*	*	AT	N
H3	87	52	M	Skin	Malignant melanoma of right heel	*	T4N1M0	III	Malignant	N
H4	88	52	M	Skin	Cancer adjacent skin tissue	*	*	*	AT	N
H5	89	51	M	Cerebrum	Glioma sarcomatosum of left temporal lobe	4	*	*	Malignant	N
H6	90	51	M	Cerebrum	Cancer adjacent cerebrum tissue	*	*	*	AT	N
H7	91	56	M	Thyroid	Papillary carcinoma	*	T2N0M0	II	Malignant	N
H8	92	56	M	Thyroid	Cancer adjacent thyroid tissue	*	*	*	AT	N
H9	93	52	M	Skin	Malignant melanoma of right heel	*	T4N1M0	III	Malignant	N
H10	94	52	M	Skin	Cancer adjacent skin tissue	*	*	*	AT	N
H11	95	51	M	Cerebrum	Glioma sarcomatosum of left temporal lobe	4	*	*	Malignant	N
H12	96	51	M	Cerebrum	Cancer adjacent cerebrum tissue	*	*	*	AT	N
I1	97									N